Reduction of seizures with low-dose clonazepam in children with epilepsy

Area of Science:

• Pediatric Neurology
• Clinical Pharmacology

Background:

• Epilepsy is a common neurological disorder in children.
• Clonazepam is an effective anti-epileptic drug, but its optimal dosing in pediatric populations requires further investigation.

Purpose of the Study:

• To evaluate the acute effects of low-dose clonazepam on seizure frequency in pediatric epilepsy patients.
• To determine the relationship between plasma clonazepam concentrations and seizure reduction.

Main Methods:

• An open-label study involving 19 children with epilepsy (generalized and partial seizures).
• Seizure frequency was monitored for 24-hour periods before and after a single intramuscular injection of low-dose clonazepam (0.01-0.04 mg/kg).
• Plasma clonazepam levels were measured to correlate with observed effects.

Main Results:

• A significant reduction in median seizure frequency from 22 to 6 was observed post-clonazepam administration (P = 0.0031).
• This reduction was associated with a median maximal plasma clonazepam level of 23 nmol/L, which is below usual therapeutic recommendations.
• A median decrease of 70% in seizure activity was noted.

Conclusions:

• Low-dose clonazepam demonstrates acute efficacy in reducing seizure frequency in children with epilepsy.
• Therapeutic anti-seizure effects can be achieved at plasma clonazepam concentrations lower than typically recommended.
• Initiating clonazepam treatment at low doses with careful individual titration is suggested to achieve optimal therapeutic outcomes while minimizing potential side effects.